Stocks To Watch: Coal India, Dr Reddy's Labs, Auto Shares In Focus Today
The domestic stock markets are likely to open on a cautious note, after closing at record highs in Tuesday's session, going by indications from SGX Nifty trading. Early SGX Nifty trends indicate a negative opening for the index in India, with a 22-point loss. At 7:30 am, the Nifty futures were trading at 13,129, lower by 22 points or 0.2 per cent on the Singapore Stock Exchange.
Market participants are awaiting RBI's scheduled bi-monthly policy review due later this week for near-term triggers.
Here are few stocks that will be in focus in Wednesday's (December 2) session:
Coal India
Coal India shares are likely to be in the limelight after the state-owned company reported a 3.4 per cent rise in production at 51.7 million tonnes (MT) in November, against an output of 50 MT in the corresponding month of the previous fiscal.
Dr Reddy's Labs
Dr Reddy's Labs counter may witness buying interest after the pharma giant, in collaboration with Russian Direct Investment Fund (RDIF), commenced clinical trials of Sputnik V vaccine in India.
Auto companies
Auto companies, including Tata Motors, Hero MotoCorp and Eicher Motors, are set to hog the limelight on the bourses after reporting stellar sales performance for the month of November.
Tata Motors' sales in the domestic and international markets rose by up 20.7 per cent to 49,650 vehicles in November 2020, from 41,124 units in the corresponding month of the previous year.
Hero MotoCorp sold 5,91,091 units of motorcycles and scooters in November 2020, as against 5,16,775 units in November 2019.
And Eicher Motors sold 63,782 motorcycles in November 2020, against 60,411 motorcycles in November 2019.
Ajanta Pharma
Ajanta Pharma shares may see some action after the company received approval from the US FDA for its high blood pressure drug, Chlorthalidone.
-
Love, Sex Aur Dhokha: The Audacious Plot To Spy On Jensen Huang
A Taipei dinner, a Singapore chip buyer and a suspected Chinese asset: inside the alleged spy operation that got close to NVIDIA's Jensen Huang.
-
Ten Things I Learnt This Samvat
Patience can be a trap. Cheap stocks can stay cheap. Leverage can wipe you out. What did Samvat 2082 teach us? Niraj Shah writes on 10 lessons from the year gone by.
-
Talking Points This Week: Tech Nerves, FII Buying, And A Faraway Banking Shock
The global markets are not shining this Diwali. The exception in the large markets is, India.
-
Midterm Rally Lasted A Day. The Hard Reality Of A Divided US May Last Two Years | Opinion
Between a contested AI boom, a debt ceiling that arrives in 2027 and a president with every incentive to act alone, the next two years may prove more volatile than the first day's rally suggests.
-
Blue Wave Will Derail the AI Trade but Won't Dismantle the AI Era | Unhedged Position
The Democrats' sweep of the US Congress will see politics collide with economic forces both over the long and short term.
-
It's Time To Take The GST Council's Bet On Trust Global
Payment records can prove India's services exports, and clear, proportionate rules can bring foreign digital sellers into the tax net.
-
Opinion | India at 38: From Innovation Overperformer to Innovation Powerhouse
India now has 453 VC-backed deep science startups, 18 of them late-stage, after 117 percent growth since 2020. Laurus Labs, at USD 9.3 billion, is the most valuable deep science company in any middle-income economy outside China.
-
Navigating Energy Crossroads: S Jaishankar's Call For Diversified Supply Chains At G20 Ministerial Meeting
As geopolitical fault lines continue to test maritime trade routes and commodity flows, Jaishankar's message remains pertinent: true economic resilience requires open markets, protected transit lines, and a genuine commitment to multilateral cooperation rather than coercion.
-
Indians Are Travelling, But Not Every Journey Is A Holiday | The Week In Whys
Pilgrims, patients and working women are the real travellers, and the system hasn't quite caught up with them.